4//SEC Filing
Culley Brian M 4
Accession 0001193125-25-327280
CIK 0000876343other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 9:55 PM ET
Size
6.9 KB
Accession
0001193125-25-327280
Insider Transaction Report
Form 4
Culley Brian M
DirectorPresident and CEO
Transactions
- Award
Common Shares
2025-12-19+8,925→ 222,469 total - Tax Payment
Common Shares
2025-12-19$1.68/sh−334$561→ 222,135 total
Footnotes (3)
- [F1]Shares earned by the Reporting Person upon the vesting of a portion of restricted stock units ("RSUs") granted to the Reporting Person on February 11, 2022 the vesting of which was subject to the achievement of certain performance conditions. RSUs are settled in common shares on a one-for-one basis.
- [F2]Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof.
- [F3]Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 8,925 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.
Documents
Issuer
Lineage Cell Therapeutics, Inc.
CIK 0000876343
Entity typeother
Related Parties
1- filerCIK 0001310683
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 9:55 PM ET
- Size
- 6.9 KB